« Previous
Next »
Titles
- Rare diseases: considerations for the development of drugs and biological products : guidance for industry1
- Real-time oncology review (RTOR): guidance for industry1
- Real-world data: assessing registries to support regulatory decision-making for drug and biological products : guidance for industry1
- Reducing Medicare’s payment rates for intermittent urinary catheters can save the program and beneficiaries millions of dollars each year1
- Reformulating drug products that contain carbomers manufactured with benzene: guidance for industry1
- Registration and listing of cosmetic product facilities and products: guidance for industry1
- Reimbursement mechanisms and challenges in team-based behavioral health care1
- Review of Medicare administrative contractor information security program evaluations for fiscal year 20221
- Review of personnel shortages in federal health care programs during the COVID-19 pandemic1
- Rhode Island Medicaid Fraud Control Unit: 2022 inspection1